TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 4 | 5 | 11 | -13 | -35 | -48 | -13 |
| P | %wins | 100 | 50 | 50 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/7/15 11:07 | 10/5/15 | OVAS | Ovascience, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jeffrey E | MA | O | CFO | P | 37 | 10.70 | 14 | 3 | 999% | 4 | D | 10 | -33 | -62 | -58 | -43 | -36 | -34 | 14 | 4 | -1 | 31 | -15 | -7 | -30 |
4/9/15 13:29 | 4/8/15 | OVAS | Ovascience, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jeffrey E | MA | O | CFO | P | 9 | 29.93 | 33 | 0 | New | 0 | D | 214 | 216 | 76 | -39 | -39 | -33 | -34 | -18 | 3 | 10 | -10 | -10 | -62 | -65 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |